Literature DB >> 8780805

Altered beta-APP metabolism after head injury and its relationship to the aetiology of Alzheimer's disease.

D I Graham1, S M Gentleman, J A Nicoll, M C Royston, J E McKenzie, G W Roberts, W S Griffin.   

Abstract

There is increasing evidence of a link between head injury and the subsequent onset of Alzheimer's disease. Deposits of amyloid beta-protein (A beta) are found not only in cases of dementia pugilistica but in some 30% of patients dying after a single episode of severe head injury. Detailed clinicopathological studies have shown that A beta deposition is most likely, but not exclusively, to occur, the older the patient at the time of injury, and if the injury is the result of a fall. Distribution studies have shown that the A beta is widely deposited in the neocortex and there is no apparent association with any of the multiple primary or secondary pathologies of traumatic brain injury. There is an increased expression of beta-APP particularly in the pre-alpha cells of the entorhinal cortex and in areas of axonal damage. Recent molecular genetic studies have shown that there is a strong association between deposits of A beta and the apolipoprotein E genotype of the individual.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8780805     DOI: 10.1007/978-3-7091-9465-2_17

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  21 in total

1.  Neuroinflammatory Cytokines-The Common Thread in Alzheimer's Pathogenesis.

Authors:  W Sue T Griffin; Steven W Barger
Journal:  US Neurol       Date:  2010

2.  D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease.

Authors:  Y Kashiwaya; T Takeshima; N Mori; K Nakashima; K Clarke; R L Veech
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

Review 3.  Disordered APP metabolism and neurovasculature in trauma and aging: Combined risks for chronic neurodegenerative disorders.

Authors:  Milos D Ikonomovic; Zhiping Mi; Eric E Abrahamson
Journal:  Ageing Res Rev       Date:  2016-11-06       Impact factor: 10.895

Review 4.  Traumatic brain injury and amyloid-β pathology: a link to Alzheimer's disease?

Authors:  Victoria E Johnson; William Stewart; Douglas H Smith
Journal:  Nat Rev Neurosci       Date:  2010-05       Impact factor: 34.870

Review 5.  Traumatic brain injury: cause or risk of Alzheimer's disease? A review of experimental studies.

Authors:  J Szczygielski; A Mautes; W I Steudel; P Falkai; T A Bayer; O Wirths
Journal:  J Neural Transm (Vienna)       Date:  2005-06-15       Impact factor: 3.575

Review 6.  Vascular and non-vascular contributors to memory reduction during traumatic brain injury.

Authors:  Mariam Charkviani; Nino Muradashvili; David Lominadze
Journal:  Eur J Neurosci       Date:  2019-03-12       Impact factor: 3.386

Review 7.  Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury.

Authors:  Ann C McKee; Robert C Cantu; Christopher J Nowinski; E Tessa Hedley-Whyte; Brandon E Gavett; Andrew E Budson; Veronica E Santini; Hyo-Soon Lee; Caroline A Kubilus; Robert A Stern
Journal:  J Neuropathol Exp Neurol       Date:  2009-07       Impact factor: 3.685

Review 8.  Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship.

Authors:  Peter T Nelson; Heiko Braak; William R Markesbery
Journal:  J Neuropathol Exp Neurol       Date:  2009-01       Impact factor: 3.685

Review 9.  The degradation of amyloid beta as a therapeutic strategy in Alzheimer's disease and cerebrovascular amyloidoses.

Authors:  Laura Morelli; Ramiro Llovera; Sandra Ibendahl; Eduardo M Castaño
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

10.  Neurochemical profile of dementia pugilistica.

Authors:  Tyler A Kokjohn; Chera L Maarouf; Ian D Daugs; Jesse M Hunter; Charisse M Whiteside; Michael Malek-Ahmadi; Emma Rodriguez; Walter Kalback; Sandra A Jacobson; Marwan N Sabbagh; Thomas G Beach; Alex E Roher
Journal:  J Neurotrauma       Date:  2013-06-01       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.